Loading...
Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges
The emergence of immune ‘checkpoint inhibitors’ such as cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed death receptor 1 (PD-1) has revolutionized treatment of solid tumors including melanoma, lung cancer, among many others. The goal of checkpoint inhibitor combination therapy is to improve...
Na minha lista:
| Udgivet i: | Immunotherapy |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Future Medicine Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5619130/ https://ncbi.nlm.nih.gov/pubmed/27349981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2016-0002 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|